Categories
BLOG

ycbd stock

Ycbd stock

No investment advice! I do this only for practicing. Info on Chart Nice uptrend, broke strong resistanc aka support from 2018 volume increasing recently Weed sector might forming a new leg up

Long YCBD Since $2.98. Can we hit $7.50 before March?

Følger sin pattern.

Still fairly new to stocks, this is an update from last post. I see a possible decline, this has had an upward pump after a downtrend and I assume with my ‘clear to understand’ trend lines that the pump is over, or this could be a fake out.

turning on all indicators; stop below MAs

Im new to stocks so take my ideas and thoughts with a grain of salt. I noticed a trend downwards and I was keeping up with the trend then it broke out of my cone, my prediction is it will go up more but I will be watching. Any ideas or thoughts of your own would be nice.

YCBD run away gap

No resistance until $2.20. Then it will retest the open, re test high (fail probably on first test), then fill the gap and moon after that. Of course anything can happen, but that would be my price action analysis. This all assuming it Opens over $1.30 anything below that this is invalidated 100%

Possible trade setup into earnings Monday after the close. Alert set for move above $1 with $1.20 as a very reasonable upside target very reasonable p/e 8.5 Company profile cbdMD, Inc. is a nationally recognized consumer cannabidiol brand which engages in producing and distributing of CBD products. Its products include CBD tinctures, CBD gummies, CBD.

Buy now and more low price. Sell levels on the chart. Profit 235-375% Good luck for you !

Bullish wedge breaking out. MACD Crossing up.

View live CBDMD INC chart to track its stock's price action. Find market predictions, YCBD financials and market news.

cbdMD, Inc. (YCBD)

Previous Close 5.1300
Open 5.1200
Bid 5.0000 x 900
Ask 4.9100 x 1100
Day’s Range 4.8100 – 5.2499
52 Week Range 0.5020 – 5.4400
Volume 1,433,233
Avg. Volume 1,149,241
Market Cap 255.161M
Beta (5Y Monthly) 1.79
PE Ratio (TTM) 17.62
EPS (TTM) 0.2770
Earnings Date Feb 09, 2021
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 5.70

Former FDA Official Engaged By cbdMD

cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has retained former US Food and Drug Administration (FDA) official Dr. Sibyl Swift as a regulatory consultant to oversee the company’s regulatory initiatives and prepare its products for further certifications.

Незабываемое путешествие

Таких впечатлений у вас еще не было. Испытайте их в Саудовской Аравии. #WelcometoArabia

cbdMD to Donate Up to $500,000 from Sales to Aid Barstool Fund

cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, announced today that it will donate up to $500,000 from its online sales to The Barstool Fund. In response to New York City’s shut down of indoor dining without a plan in place, David Portnoy and Barstool Sports have set up The Barstool Fund. The fund is not only helping restaurants and bars, but it is here for all small businesses around the country in need of help due to the effects of COVID-19. In under two months, Barstool Sports has raised over $30 million and has reached out to more than 150 businesses and counting.

cbdMD, Inc. To Host Conference Call To Discuss December 31, 2020, First Quarter Results

cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the world’s leading, and most highly trusted and recognized health & wellness CBD companies, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Tuesday, February 9, 2021, to discuss the company’s December 31, 2020 first quarter financial results and business progress.

cbdMD Extends Sponsorship With Professional Rally Driver Megastar Ken Block

cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that the company is renewing its partnership with Ken Block, professional rally and rallycross driver currently with the Hoonigan Racing division. Through this renewed sponsorship with cbdMD, the brand is set to become synonymous with Block’s rally car races, with the cbdMD logo to appear on his official fire suit and rally car. The extended sponsorship deal will also include a wide range of additional integrated marketing opportunities to promote the cbdMD brand.

Could The cbdMD, Inc. (NYSEMKT:YCBD) Ownership Structure Tell Us Something Useful?

The big shareholder groups in cbdMD, Inc. ( NYSEMKT:YCBD ) have power over the company. Generally speaking, as a.

cbdMD Enters Global Beauty and Skincare Market With Launch of “cbdMD Botanicals”

cbdMD, Inc.​ (NYSE American: YCBD, YCBDpA) (the “Company”)​, one of the world’s leading, and most highly trusted and recognized CBD health and wellness companies, announced today that it is entering the global beauty and skincare market with the brand’s launch of “cbdMD Botanicals”. The new beauty and skincare line features 15 luxury products, including: Facial Oil and Serum, Toner, Moisturizers, Clearskin, Facial Masks, Exfoliants, and Body Care.

cbdMD Grows Direct-to-Consumer Footprint with U.K. Expansion

cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that the company is expanding its direct-to-consumer operations into the United Kingdom (U.K.), officially launching its new website exclusively for customers in the U.K.

cbdMD Reports Fiscal September 30, 2020 Results

cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, today announced its financial results for the fourth quarter and fiscal year ended September 30, 2020.

cbdMD, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / December 22, 2020 / cbdMD, Inc.

cbdMD, Inc. To Host Conference Call To Discuss September 30, 2020, Fourth Quarter and Fiscal Year End Results

cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Tuesday, December 22, 2020, to discuss the company’s September 30, 2020 fourth quarter and fiscal year end financial results and business progress.

Strong Retail Sales Performance and Sell Through Result In Regional Grocer Save Mart To Expand cbdMD and Paw CBD Brand Offerings To Additional 100 Locations

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) announced that regional grocer Save Mart has agreed to expand their cbdMD product offerings to additional locations due to strong retail sales performance and sell through of cbdMD and Paw CBD brands.

cbdMD, Inc. Announces Closing of $17,250,000 Underwritten Public Offering of Its 8.0% Series A Cumulative Convertible Preferred Stock

cbdMD, Inc. (NYSE American: YCBD, YCBDpA), today announced the closing of its previously announced underwritten public offering for total gross proceeds of $17,250,000, before deducting underwriting discounts, commissions and other offering expenses payable by the company. cbdMD, Inc. sold an aggregate of 2,300,000 shares of its 8.0% Series A Cumulative Convertible Preferred Stock at a purchase price of $7.50 per share in this offering which included the full exercise of the over-allotment option of 300,000 shares. cbdMD, Inc. intends to use the net proceeds from the offering for working capital.

cbdMD, Inc. Announces Pricing of $15 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering

cbdMD, Inc. (NYSE American: YCBD, YCBDpA) today announced the pricing of its underwritten public offering of 2,000,000 shares of its 8.0% Series A Cumulative Convertible Preferred Stock at a price to the public of $7.50 per share. cbdMD expects to receive gross proceeds of $15,000,000 from the offering. The closing of the offering is expected to occur on or about December 11, 2020, subject to the satisfaction of customary closing conditions. The shares will be convertible into shares of cbdMD’s common stock at the holder’s option at a conversion price of $6.00 per share, or by cbdMD at a conversion price of $6.00 per share if the trading price of its common stock equals or exceeds $8.25 per share for at least 20 trading days in any 30 consecutive trading day period ending five days prior to the date of notice of conversion. The shares will not be redeemable prior to October 16, 2023, except upon the occurrence of a change of control.

cbdMD Announces Speaking Engagement at the Cowen 2020 Boston Cannabis Conference

cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, today announced that Martin Sumichrast, Chairman & Co-CEO, is scheduled to speak on the CBD panel at the Cowen 2020 Boston Cannabis Conference on Tuesday, December 1, 2020 at 1:30 p.m. EST.

Is cbdMD, Inc. (YCBD) A Good Stock To Buy Now?

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don’t make them change their opinion towards a company. This time it may be different. The coronavirus pandemic destroyed the high correlations among major industries and asset classes. We are […]

cbdMD Announces Participation in Jefferies Virtual West Coast Consumer Conference

cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it will be participating in the Jefferies Virtual West Coast Consumer Conference, November 16-18, 2020. cbdMD Co-CEO & President, Scott Coffman, will be the guest speaker for the company’s Fireside Chat session, with Jefferies analyst, Owen Bennett.

cbdMD Releases ‘Premium Relieve’ with Lidocaine, Expanding Upon Diverse Topical Offerings Featuring Superior Broad Spectrum CBD Formula

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today an expansion of its topical product line with the launch of ‘Premium Relieve’, a product that combines the pain-fighting power of Lidocaine with Superior Broad Spectrum CBD extracts – leading to total wellness in one unique topical formula.

cbdMD Engages Leading Biotech Firm IONTOX to Validate Its Patent Pending Superior Broad Spectrum Blend

cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has retained nationally recognized biotechnology company IONTOX (https://www.iontox.com), to validate the Company’s patent pending proprietary cannabinoid formulations. On July 9, 2020, cbdMD announced it had filed provisional patents on its novel formulations and delivery systems. This is the next step in demonstrating the safety and efficacy of those formulations, including a new water-soluble formulation for beverages.

cbdMD Seeks To Obtain Regulatory Approval From United Kingdom’s Regulatory Food Safety Agency (FSA)

cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, confirmed today that it is on track to submit its Novel Foods Dossier with the United Kingdom’s Food Safety Agency (FSA) by the required regulatory filing deadline of March 31, 2021.

USA Today’s Golfweek Reports On Professional Golfer Bubba Watson’s Battle With Anxieties; cbdMD Plays Strong Role in his Ongoing Health and Wellness Journey

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that USA Today’s GolfWeek published a story on October 28, 2020 about two time Masters Champion, and Team cbdMD Athlete, Bubba Watson, in which Bubba discussed his personal and professional anxieties and cbdMD’s role relative to his ongoing health and wellness regimen.

cbdMD, Inc. Reports Preliminary Fourth Quarter Fiscal 2020 Net Sales For Its Paw CBD Brand; Sequential Quarterly Net Sales Expected to Increase Between 30% and 34%

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that its CBD pet products brand, Paw CBD, has experienced another record quarter of net sales. Paw CBD’s September 30, 2020, estimated preliminary quarterly net sales are expected to range between $1.6 million and $1.65 million, or a sequential quarterly growth of between 30% and 34% from the $1.23 million in net sales in the prior quarter ended June 30, 2020.

Life Time To Expand cbdMD Product Sales In All Cafes Due To Strong Retail Sales Performance and Sell Through

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) announced today that Life Time, the nation’s premier healthy lifestyle brand, will be expanding their cbdMD product sales into all its Life Time Cafes nationwide as of November 1, 2020, due to the brands’ strong retail sales performance and sell through. As a wellness pioneer, Life Time is reshaping the way consumers approach their health by integrating where consumers play, work and live – all with the primary objective of helping people lead healthy, happy lives. With more than 150 destinations in 41 major markets across the U.S. and Canada, Life Time operates luxury athletic resorts, owns and produces iconic athletic events and is expanding its brand though Life Time Work premium coworking spaces and Life Time Living high-end leased residences.

cbdMD Reports Preliminary Fourth Quarter and Fiscal 2020 Results

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, highly trusted, and most recognized cannabidiol (CBD) brands, today reported the following preliminary financial results for the fourth quarter of fiscal 2020 and the year ended September 30, 2020.

Distribution Company PRO Group, Inc. Selects cbdMD and Paw CBD As Exclusive CBD Brands

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, most highly trusted, and most recognized cannabidiol (CBD) brands, announced today that PRO Group, Inc. (www.pro-group.com), a multidivisional international merchandising and marketing organization, with over 79 distributors operating over 140 distribution centers serving all 50 states and combined sales volume exceeding $6 billion through its member distributors and an alliance with the VAL-TEST Group, has selected cbdMD and Paw CBD and the CBD brands to distribute through its national network effective immediately.

Federman & Sherwood Initiates an Investigation of the Data Breach at cbdMD, Inc.

Federman & Sherwood Initiates an Investigation of the Data Breach at cbdMD, Inc.

Find the latest cbdMD, Inc. (YCBD) stock quote, history, news and other vital information to help you with your stock trading and investing.